Warning: count(): Parameter must be an array or an object that implements Countable in /home/logicben/public_html/drugtrialsformoney.com/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 391

ClinicalTrials.gov

Author's Posts:
Electroencephalographic Changes Under General Anesthesia in Patients With Gynecologic Cancers With and Without History of Chemotherapy
Condition:   Malignant Female Reproductive System Neoplasm
Interventions:   Procedure: Biospecimen Collection;   Behavioral: BrainCheck Cognitive Assessment;   Procedure: Cognitive Assessment;   Procedure: Electroencephalography
Sponsor:   M.D. Anderson Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
Condition:   Major Depressive Disorder
Intervention:   Drug: Psilocybin
Sponsor:   Maryland Oncology Hematology, PA
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
Longitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in People With Acquired Vestibulopathy
Conditions:   Vestibular Schwannoma;   Vestibular Disorder
Intervention:   Behavioral: Gaze and Postural Retraining Exercise
Sponsor:   University of Utah
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma
Condition:   Melanoma
Interventions:   Other: Immunotherapy;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
Condition:   Lung Carcinoma
Interventions:   Other: Educational Intervention;   Other: Questionnaire Administration;   Other: Survey Administration
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
IORT-Breast at MCNH
Conditions:   Breast Cancer Female;   Early-stage Breast Cancer
Interventions:   Procedure: Lumpectomy;   Radiation: Intraoperative Radiation Therapy
Sponsor:   Navicent Health
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic PC Patients
Condition:   Metastatic Pancreatic Ductal Adenocarcinoma
Intervention:   Drug: Canakinumab injection; spartalizumab, nab-paclitaxel, gemcitabine
Sponsors:   Pancreatic Cancer Action Network;   Novartis Pharmaceuticals
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
Identification of Anxiety and Depression in Adolescents/Young Adults (AYA) With Cancer
Conditions:   Cancer;   Depression, Anxiety
Intervention:  
Sponsor:   University of Texas Southwestern Medical Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
INCMGA00012 (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
Conditions:   Soft Tissue Sarcoma;   Sarcoma,Soft Tissue;   Sarcoma;   Soft Tissue Sarcoma Adult
Interventions:   Drug: INCMGA00012;   Drug: Gemcitabine;   Drug: Docetaxel
Sponsors:   Memorial Sloan Kettering Cancer Center;   Incyte Corporation
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
Condition:   Malignant Pleural Mesothelioma (MPM)
Interventions:   Drug: cyclophosphamide;   Biological: CAR T cells
Sponsor:   Memorial Sloan Kettering Cancer Center
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 21, 2020 / by / in